Previous Article | Next Article 
Molecular and Cellular Biology, April 2004, p. 3251-3261, Vol. 24, No. 8
0270-7306/04/$08.00+0 DOI: 10.1128/MCB.24.8.3251-3261.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
pVHL Modification by NEDD8 Is Required for Fibronectin Matrix Assembly and Suppression of Tumor Development
Natalie H. Stickle,1 Jacky Chung,1 Jeffery M. Klco,2 Richard P. Hill,3 William G. Kaelin Jr.,4 and Michael Ohh1*
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5S 1A8,1
Department of Medical Biophysics, University of Toronto and Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario M5G 2M9, Canada,3
Washington University School of Medicine, St. Louis, Missouri 63110,2
Department of Molecular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, and Howard Hughes Medical Institute, Boston, Massachusetts 021154
Received 25 June 2003/
Returned for modification 13 August 2003/
Accepted 8 January 2004
Functional inactivation of the von Hippel-Lindau (VHL) tumor suppressor gene is the cause of the familial VHL disease and most sporadic renal clear-cell carcinomas (RCC). pVHL has been shown to play a role in the destruction of hypoxia-inducible factor
(HIF-
) subunits via ubiquitin-mediated proteolysis and in the regulation of fibronectin matrix assembly. Although most disease-causing pVHL mutations hinder the regulation of the HIF pathway, every disease-causing pVHL mutant tested to date has failed to promote the assembly of the fibronectin matrix, underscoring its potential importance in VHL disease. Here, we report that a ubiquitin-like molecule called NEDD8 covalently modifies pVHL. A nonneddylateable pVHL mutant, while retaining its ability to ubiquitylate HIF, failed to bind to and promote the assembly of the fibronectin matrix. Expression of the neddylation-defective pVHL in RCC cells, while restoring the regulation of HIF, failed to promote the differentiated morphology in a three-dimensional growth assay and was insufficient to suppress the formation of tumors in SCID mice. These results suggest that NEDD8 modification of pVHL plays an important role in fibronectin matrix assembly and that in the absence of such regulation, an intact HIF pathway is insufficient to prevent VHL-associated tumorigenesis.
* Corresponding author. Mailing address: Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada. Phone: (416) 946-7922. Fax: (416) 978-5959. E-mail: michael.ohh{at}utoronto.ca.
Molecular and Cellular Biology, April 2004, p. 3251-3261, Vol. 24, No. 8
0022-538X/04/$08.00+0 DOI: 10.1128/MCB.24.8.3251-3261.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Feijoo-Cuaresma, M., Mendez, F., Maqueda, A., Esteban, M. A., Naranjo-Suarez, S., Castellanos, M. C., del Cerro, M. H., Vazquez, S. N., Garcia-Pardo, A., Landazuri, M. O., Calzada, M. J.
(2008). Inadequate Activation of the GTPase RhoA Contributes to the Lack of Fibronectin Matrix Assembly in von Hippel-Lindau Protein-defective Renal Cancer Cells. J. Biol. Chem.
283: 24982-24990
[Abstract]
[Full Text]
-
Groenman, F., Rutter, M., Caniggia, I., Tibboel, D., Post, M.
(2007). Hypoxia-inducible Factors in the First Trimester Human Lung. J. Histochem. Cytochem.
55: 355-363
[Abstract]
[Full Text]
-
Evans, A. J., Russell, R. C., Roche, O., Burry, T. N., Fish, J. E., Chow, V. W. K., Kim, W. Y., Saravanan, A., Maynard, M. A., Gervais, M. L., Sufan, R. I., Roberts, A. M., Wilson, L. A., Betten, M., Vandewalle, C., Berx, G., Marsden, P. A., Irwin, M. S., Teh, B. T., Jewett, M. A. S., Ohh, M.
(2007). VHL Promotes E2 Box-Dependent E-Cadherin Transcription by HIF-Mediated Regulation of SIP1 and Snail. Mol. Cell. Biol.
27: 157-169
[Abstract]
[Full Text]
-
Iliopoulos, O.
(2006). Molecular Biology of Renal Cell Cancer and the Identification of Therapeutic Targets. JCO
24: 5593-5600
[Abstract]
[Full Text]
-
Watson, I. R., Blanch, A., Lin, D. C. C., Ohh, M., Irwin, M. S.
(2006). Mdm2-mediated NEDD8 Modification of TAp73 Regulates Its Transactivation Function. J. Biol. Chem.
281: 34096-34103
[Abstract]
[Full Text]
-
de Laplanche, E., Gouget, K., Cleris, G., Dragounoff, F., Demont, J., Morales, A., Bezin, L., Godinot, C., Perriere, G., Mouchiroud, D., Simonnet, H.
(2006). Physiological oxygenation status is required for fully differentiated phenotype in kidney cortex proximal tubules. Am. J. Physiol. Renal Physiol.
291: F750-F760
[Abstract]
[Full Text]
-
Ray, D., Osmundson, E. C., Kiyokawa, H.
(2006). Constitutive and UV-induced Fibronectin Degradation Is a Ubiquitination-dependent Process Controlled by beta-TrCP. J. Biol. Chem.
281: 23060-23065
[Abstract]
[Full Text]
-
Tanji, K., Tanaka, T., Mori, F., Kito, K., Takahashi, H., Wakabayashi, K., Kamitani, T.
(2006). NUB1 Suppresses the Formation of Lewy Body-Like Inclusions by Proteasomal Degradation of Synphilin-1. Am. J. Pathol.
169: 553-565
[Abstract]
[Full Text]
-
Lutz, M. S., Burk, R. D.
(2006). Primary cilium formation requires von hippel-lindau gene function in renal-derived cells.. Cancer Res.
66: 6903-6907
[Abstract]
[Full Text]
-
Esteban, M. A., Harten, S. K., Tran, M. G., Maxwell, P. H.
(2006). Formation of Primary Cilia in the Renal Epithelium Is Regulated by the von Hippel-Lindau Tumor Suppressor Protein. J. Am. Soc. Nephrol.
17: 1801-1806
[Abstract]
[Full Text]
-
Hsu, T., Adereth, Y., Kose, N., Dammai, V.
(2006). Endocytic Function of von Hippel-Lindau Tumor Suppressor Protein Regulates Surface Localization of Fibroblast Growth Factor Receptor 1 and Cell Motility. J. Biol. Chem.
281: 12069-12080
[Abstract]
[Full Text]
-
Tang, N., Mack, F., Haase, V. H., Simon, M. C., Johnson, R. S.
(2006). pVHL Function Is Essential for Endothelial Extracellular Matrix Deposition.. Mol. Cell. Biol.
26: 2519-2530
[Abstract]
[Full Text]
-
Kurban, G., Hudon, V., Duplan, E., Ohh, M., Pause, A.
(2006). Characterization of a von Hippel Lindau Pathway Involved in Extracellular Matrix Remodeling, Cell Invasion, and Angiogenesis. Cancer Res.
66: 1313-1319
[Abstract]
[Full Text]
-
Calzada, M. J., Esteban, M. A., Feijoo-Cuaresma, M., Castellanos, M. C., Naranjo-Suarez, S., Temes, E., Mendez, F., Yanez-Mo, M., Ohh, M., Landazuri, M. O.
(2006). von Hippel-Lindau Tumor Suppressor Protein Regulates the Assembly of Intercellular Junctions in Renal Cancer Cells through Hypoxia-Inducible Factor-Independent Mechanisms. Cancer Res.
66: 1553-1560
[Abstract]
[Full Text]
-
Smith, K., Gunaratnam, L., Morley, M., Franovic, A., Mekhail, K., Lee, S.
(2005). Silencing of Epidermal Growth Factor Receptor Suppresses Hypoxia-Inducible Factor-2-Driven VHL-/- Renal Cancer. Cancer Res.
65: 5221-5230
[Abstract]
[Full Text]
-
Lolkema, M. P., Gervais, M. L., Snijckers, C. M., Hill, R. P., Giles, R. H., Voest, E. E., Ohh, M.
(2005). Tumor Suppression by the von Hippel-Lindau Protein Requires Phosphorylation of the Acidic Domain. J. Biol. Chem.
280: 22205-22211
[Abstract]
[Full Text]
Copyright © 2004 by the American Society for Microbiology. All rights reserved.